OBJECTIVE: To examine the efficacy of ultrasound (US)-guided injections for midfoot joint degenerative changes. MATERIALS AND METHODS: The US images and radiographs of 63 patients with midfoot joint degenerative changes were retrospectively reviewed. In those patients who had US-guided intra-articular steroid injection, the response to the injection was recorded by reviewing the 2-week pain diaries and clinical notes. Partial or complete pain relief was defined as a positive response and the same or increased level of pain as a negative response to the injection. RESULTS: Fifty-nine (59/63, 93.6%) patients with midfoot joint degenerative changes received US-guided injection. The majority of patients had a positive response up to 3 months post-injection (78.4% still experiencing pain relief at 2 weeks, 57.5% at 3 months and fewer than 15% of patients further than 3 months post-injection). The number of positive therapeutic responses did not differ significantly between patients with diagnostic and non-diagnostic response (p = 0.2636). CONCLUSIONS: US-guided intra-articular injections for midfoot degenerative changes can have a good therapeutic result in the majority of patients up to 3 months post-injection. Therapeutic response cannot be predicted by a positive diagnostic response.
OBJECTIVE: To examine the efficacy of ultrasound (US)-guided injections for midfoot joint degenerative changes. MATERIALS AND METHODS: The US images and radiographs of 63 patients with midfoot joint degenerative changes were retrospectively reviewed. In those patients who had US-guided intra-articularsteroid injection, the response to the injection was recorded by reviewing the 2-week pain diaries and clinical notes. Partial or complete pain relief was defined as a positive response and the same or increased level of pain as a negative response to the injection. RESULTS: Fifty-nine (59/63, 93.6%) patients with midfoot joint degenerative changes received US-guided injection. The majority of patients had a positive response up to 3 months post-injection (78.4% still experiencing pain relief at 2 weeks, 57.5% at 3 months and fewer than 15% of patients further than 3 months post-injection). The number of positive therapeutic responses did not differ significantly between patients with diagnostic and non-diagnostic response (p = 0.2636). CONCLUSIONS: US-guided intra-articular injections for midfoot degenerative changes can have a good therapeutic result in the majority of patients up to 3 months post-injection. Therapeutic response cannot be predicted by a positive diagnostic response.
Authors: I Möller; D Bong; E Naredo; E Filippucci; I Carrasco; C Moragues; A Iagnocco Journal: Osteoarthritis Cartilage Date: 2008-08-29 Impact factor: 6.576
Authors: Jeannie Chao; Christopher Wu; Bob Sun; Michal Kalli Hose; Anna Quan; Tudor H Hughes; David Boyle; Kenneth C Kalunian Journal: J Rheumatol Date: 2010-01-15 Impact factor: 4.666
Authors: Shannon E Munteanu; Hylton B Menz; Gerard V Zammit; Karl B Landorf; Christopher J Handley; Ayman Elzarka; Jason Deluca Journal: J Foot Ankle Res Date: 2009-01-16 Impact factor: 2.303
Authors: Martin J Thomas; George Peat; Trishna Rathod; Michelle Marshall; Andrew Moore; Hylton B Menz; Edward Roddy Journal: Arthritis Res Ther Date: 2015-07-13 Impact factor: 5.156
Authors: Trishna Rathod; Michelle Marshall; Martin J Thomas; Hylton B Menz; Helen L Myers; Elaine Thomas; Thomas Downes; George Peat; Edward Roddy Journal: Arthritis Care Res (Hoboken) Date: 2016-02 Impact factor: 4.794